Seventeen top-selling brand-name drugs saw their prices more than double over a six-year period, according to a new study published in The Journal of the American Medical Association.

Johnson & Johnson was ordered by a jury to pay $300 million in punitive damages to a woman who claimed the company's talc-based products caused her asbestos-related cancer, according to CNBC.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

Blink Health, an online discount pharmacy startup, has lowered prices for 148 of its most common generic drugs.

Merrimack Pharmaceuticals will lay off its entire staff, including its CEO and CFO, as operations continue to wind down over the next two months, according to Biospace.

A recent article by Premier dives into why health systems are honing in on drug spending to increase margins and limit the overall costs. 

In its inaugural Drug Pipeline Insights Report, OptumRx highlights five drugs expected to make waves soon in the healthcare industry for clinical quality, effectiveness and cost. They are listed below:

Blink Health, an e-commerce platform that connects people to lower-priced medications, has hired three former Amazon veterans to serve on its senior leadership team, according to Business Insider.

The FDA has ordered Pharm D Solutions, a Texas compounding pharmacy, to cease all sterile compounding operations and distribution.

The PBM market is dominated by three major players, who together handled about 76 percent of all prescription claims in 2018, according to Drug Channels Institute.